Correlation Between Genovate Biotechnology and CHC Healthcare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genovate Biotechnology and CHC Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genovate Biotechnology and CHC Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genovate Biotechnology Co and CHC Healthcare Group, you can compare the effects of market volatilities on Genovate Biotechnology and CHC Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genovate Biotechnology with a short position of CHC Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genovate Biotechnology and CHC Healthcare.

Diversification Opportunities for Genovate Biotechnology and CHC Healthcare

0.47
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Genovate and CHC is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Genovate Biotechnology Co and CHC Healthcare Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CHC Healthcare Group and Genovate Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genovate Biotechnology Co are associated (or correlated) with CHC Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CHC Healthcare Group has no effect on the direction of Genovate Biotechnology i.e., Genovate Biotechnology and CHC Healthcare go up and down completely randomly.

Pair Corralation between Genovate Biotechnology and CHC Healthcare

Assuming the 90 days trading horizon Genovate Biotechnology Co is expected to generate 3.26 times more return on investment than CHC Healthcare. However, Genovate Biotechnology is 3.26 times more volatile than CHC Healthcare Group. It trades about 0.01 of its potential returns per unit of risk. CHC Healthcare Group is currently generating about -0.05 per unit of risk. If you would invest  2,896  in Genovate Biotechnology Co on September 2, 2024 and sell it today you would lose (711.00) from holding Genovate Biotechnology Co or give up 24.55% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Genovate Biotechnology Co  vs.  CHC Healthcare Group

 Performance 
       Timeline  
Genovate Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genovate Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Genovate Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
CHC Healthcare Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CHC Healthcare Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Genovate Biotechnology and CHC Healthcare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genovate Biotechnology and CHC Healthcare

The main advantage of trading using opposite Genovate Biotechnology and CHC Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genovate Biotechnology position performs unexpectedly, CHC Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CHC Healthcare will offset losses from the drop in CHC Healthcare's long position.
The idea behind Genovate Biotechnology Co and CHC Healthcare Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated